Literature DB >> 31560942

Designing traceable opioid material§ kits to improve laboratory testing during the U.S. opioid overdose crisis.

Mike A Mojica1, Melissa D Carter2, Samantha L Isenberg1, James L Pirkle1, Elizabeth I Hamelin1, Rebecca L Shaner1, Craig Seymour1, Cody I Sheppard1, Grant T Baldwin3, Rudolph C Johnson1.   

Abstract

In 2017, the U.S. Department of Health and Human Services and the White House declared a public health emergency to address the opioid crisis (Hargan, 2017). On average, 192 Americans died from drug overdoses each day in 2017; 130 (67%) of those died specifically because of opioids (Scholl et al., 2019). Since 2013, there have been significant increases in overdose deaths involving synthetic opioids - particularly those involving illicitly-manufactured fentanyl. The U.S. Drug Enforcement Administration (DEA) estimates that 75% of all opioid identifications are illicit fentanyls (DEA, 2018b). Laboratories are routinely asked to confirm which fentanyl or other opioids are involved in an overdose or encountered by first responders. It is critical to identify and classify the types of drugs involved in an overdose, how often they are involved, and how that involvement may change over time. Health care providers, public health professionals, and law enforcement officers need to know which opioids are in use to treat, monitor, and investigate fatal and non-fatal overdoses. By knowing which drugs are present, appropriate prevention and response activities can be implemented. Laboratory testing is available for clinically used and widely recognized opioids. However, there has been a rapid expansion in new illicit opioids, particularly fentanyl analogs that may not be addressed by current laboratory capabilities. In order to test for these new opioids, laboratories require reference standards for the large number of possible fentanyls. To address this need, the Centers for Disease Control and Prevention (CDC) developed the Traceable Opioid Material§ Kits product line, which provides over 150 opioid reference standards, including over 100 fentanyl analogs. These kits were designed to dramatically increase laboratory capability to confirm which opioids are on the streets and causing deaths. The kits are free to U.S based laboratories in the public, private, clinical, law enforcement, research, and public health domains. Published by Elsevier B.V.

Entities:  

Keywords:  FAS Kit; Fentanyl; Fentanyl Analog Screening Kit; Fentanyl analogs; Opioid; Opioid CRM Kit; Opioid Certified Reference Material Kit; Opioid overdose crisis; TOM Kits(§); Traceable Opioid Material(§) Kits

Mesh:

Substances:

Year:  2019        PMID: 31560942      PMCID: PMC6855243          DOI: 10.1016/j.toxlet.2019.09.017

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  17 in total

1.  Friedrich Wilhelm Sertürner and the discovery of morphine.

Authors:  R Schmitz
Journal:  Pharm Hist       Date:  1985

2.  Drug Overdose Deaths: Let's Get Specific.

Authors:  Svetla Slavova; Daniella Bradley O'Brien; Kathleen Creppage; Dan Dao; Anna Fondario; Elizabeth Haile; Beth Hume; Thomas W Largo; Claire Nguyen; Jennifer C Sabel; Dagan Wright
Journal:  Public Health Rep       Date:  2015 Jul-Aug       Impact factor: 2.792

3.  Heroin uncertainties: Exploring users' perceptions of fentanyl-adulterated and -substituted 'heroin'.

Authors:  Daniel Ciccarone; Jeff Ondocsin; Sarah G Mars
Journal:  Int J Drug Policy       Date:  2017-07-18

4.  The first reported fatality associated with the synthetic opioid 3,4-dichloro-N-[2-(dimethylamino)cyclohexyl]-N-methylbenzamide (U-47700) and implications for forensic analysis.

Authors:  Simon P Elliott; Simon D Brandt; Christopher Smith
Journal:  Drug Test Anal       Date:  2016-05-27       Impact factor: 3.345

5.  Chemical Attribution of Fentanyl Using Multivariate Statistical Analysis of Orthogonal Mass Spectral Data.

Authors:  Brian P Mayer; Alan J DeHope; Daniel A Mew; Paul E Spackman; Audrey M Williams
Journal:  Anal Chem       Date:  2016-03-30       Impact factor: 6.986

6.  4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents.

Authors:  L V Kudzma; S A Severnak; M J Benvenga; E F Ezell; M H Ossipov; V V Knight; F G Rudo; H K Spencer; T C Spaulding
Journal:  J Med Chem       Date:  1989-12       Impact factor: 7.446

7.  Pharmacological profiles of fentanyl analogs at mu, delta and kappa opiate receptors.

Authors:  P Maguire; N Tsai; J Kamal; C Cometta-Morini; C Upton; G Loew
Journal:  Eur J Pharmacol       Date:  1992-03-24       Impact factor: 4.432

8.  Deaths Involving Fentanyl, Fentanyl Analogs, and U-47700 - 10 States, July-December 2016.

Authors:  Julie K O'Donnell; John Halpin; Christine L Mattson; Bruce A Goldberger; R Matthew Gladden
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2017-11-03       Impact factor: 17.586

9.  Drugs, Devices, and the FDA: Part 1: An Overview of Approval Processes for Drugs.

Authors:  Gail A Van Norman
Journal:  JACC Basic Transl Sci       Date:  2016-04-25

10.  Drug and Opioid-Involved Overdose Deaths - United States, 2013-2017.

Authors:  Lawrence Scholl; Puja Seth; Mbabazi Kariisa; Nana Wilson; Grant Baldwin
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2018-01-04       Impact factor: 17.586

View more
  1 in total

1.  Application of the fentanyl analog screening kit toward the identification of emerging synthetic opioids in human plasma and urine by LC-QTOF.

Authors:  Logan C Krajewski; Kenneth D Swanson; William A Bragg; Rebecca L Shaner; Craig Seymour; Melissa D Carter; Elizabeth I Hamelin; Rudolph C Johnson
Journal:  Toxicol Lett       Date:  2019-12-05       Impact factor: 4.372

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.